Know Cancer

or
forgot password

PICASSO Study: a Cohort Study of Patients With Metastatic Colorectal Cancer Treated With Avastin as First-line Therapy for Hepatic Metastases Considered as Potentially Resectable


N/A
18 Years
N/A
Open (Enrolling)
Both
Colorectal Cancer

Thank you

Trial Information

PICASSO Study: a Cohort Study of Patients With Metastatic Colorectal Cancer Treated With Avastin as First-line Therapy for Hepatic Metastases Considered as Potentially Resectable


Inclusion Criteria:



- Adult patients, >/= 18 years of age

- Colorectal cancer with exclusively hepatic or hepatic and pulmonary metastases

- First-line treatment with Avastin for potentially resectable metastatic disease

Exclusion Criteria:

- Outright resectable disease

- Clearly inoperable disease

- Participation in a clinical trial evaluating a cytotoxic anticancer treatment and/or
an innovative therapy

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Response rate, defined as rate of patients without detectable metastases (after 1st-line treatment with or without surgery)

Outcome Time Frame:

approximately 4 years

Safety Issue:

No

Principal Investigator

Clinical Trials

Investigator Role:

Study Director

Investigator Affiliation:

Hoffmann-La Roche

Authority:

France: Commission Nationale de l'Informatique et des Libert├ęs (CNIL)

Study ID:

ML22999

NCT ID:

NCT01343901

Start Date:

September 2010

Completion Date:

September 2015

Related Keywords:

  • Colorectal Cancer
  • Colorectal Neoplasms
  • Neoplasm Metastasis

Name

Location